
    
      This was an open-label, balanced, randomized, two-treatment, two-period, two-sequence,single
      dose, crossover bioequivalence study in healthy, adult, human, male subjects under
      non-fasting conditions.92 healthy male adults were enrolled.A washout period of 07 days was
      maintained between the successive dosing days.One tablet containing mycophenolate mofetil 500
      mg was administered orally with 240 mL water in sitting posture, after 30 minutes of serving
      of the high fat and high calorie breakfast in each period. This activity was followed by a
      mouth check to assess compliance to dosing. The subjects were not allowed to lie down for the
      first three hours after dosing.
    
  